A neurotrophic cognition stack anchored by cerebrolysin, with the Selank-family peptide for anxiolytic focus.
Cerebrolysin is a peptide preparation with neurotrophic, BDNF-like activity, studied in cognitive and neuro-recovery settings — it's the most clinically-backed anchor for a cognition goal. It's typically run in courses rather than continuously.
N-Acetyl Selank Amidate (a stabilised Selank derivative) is added for its anxiolytic, focus-supporting profile without the sedation of typical anxiolytics. This is a nootropic-leaning stack; the usual caveat applies that cognitive-enhancement evidence in healthy people is thinner than in clinical populations.
| Compound | Role | Dose | Frequency |
|---|---|---|---|
| Cerebrolysin Neurotrophic, BDNF-like; run in courses. | Primary | 10-50mL depending on indication (stroke/TBI higher doses) | Once daily for acute conditions; 5 days weekly for chronic conditions |
| NA-Selank Amidate Anxiolytic, focus-supporting Selank derivative. | Support | 200-500mcg per administration | 1-2x daily for 14-20 days |